Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Development ofMB-2003, a novel monoclonal antibody (mAB) based countermeasure with antiviral activity against Ebola virus
Geisbert, Thomas
(PI)
Microbiology And Immunology
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
4/19/16
→
5/31/17
Funding
Mapp Biopharmaceutical, Inc ( Award #HDTRA113C0018):
$558,281.00
View all
View less